Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. [electronic resource]
- Vaccine Mar 2008
- 1742-50 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
0264-410X
10.1016/j.vaccine.2008.01.036 doi
Animals Antibodies, Viral--analysis Antibody Specificity Cross Reactions Disease Outbreaks--prevention & control Ferrets Humans Influenza A Virus, H7N7 Subtype--growth & development Influenza Vaccines--immunology Influenza, Human--immunology Mice Models, Molecular Phenotype Reassortant Viruses--growth & development Vaccines, Inactivated--immunology